Does loneliness impact intentional weight loss? The role of obesity-related disadvantages and comorbidities




Männistö, Siniriikka A.; Joki, Anu; Suojanen, Laura-Unnukka; Venäläinen, Mikko S.; Pietiläinen, Kirsi H.; Ahola, Aila J.

PublisherElsevier

2026

 Preventive Medicine

108430

202

0091-7435

1096-0260

DOIhttps://doi.org/10.1016/j.ypmed.2025.108430

https://doi.org/10.1016/j.ypmed.2025.108430

https://research.utu.fi/converis/portal/detail/Publication/504734866



Objective

Loneliness is increasingly recognized as a significant factor influencing health outcomes, including weight management. Nevertheless, its role in intentional weight loss remains underexplored. The 12-month digital Healthy Weight Coaching (HWC), in Finland, offers a real-world context to investigate this relationship. We explored whether baseline loneliness affects weight loss during HWC and whether comorbidities or perceived obesity-related disadvantages mediate this relationship.

Methods

Data were included from participants enrolled in the HWC between 2016 and 2020. Baseline assessments included loneliness, comorbidities, and perceived obesity-related disadvantages. Weight was self-reported weekly, with body mass index calculated from interpolated weights at three, six, nine, and 12 months. Generalized estimating equations were used to analyze the impact of baseline loneliness on weight change, and ordinary least squares regression analyses were used to analyze mediation.

Results

Participants who felt lonely, somewhat lonely, or not lonely at baseline achieved comparable weight loss. However, higher loneliness was linked to greater perceived obesity-related disadvantages, psychological distress, number of comorbidities, and lower vitality, indirectly leading to lesser weight loss.

Conclusions

Loneliness did not directly hinder weight loss but was linked to health and psychosocial challenges that may indirectly reduce success, highlighting the need for holistic support in weight management.


This study was supported by Academy of Finland, grant numbers 266286, 272376, 314383, and 335443); Finnish Medical Foundation; Gyllenberg Foundation; Novo Nordisk Foundation, grant numbers NNF20OC0060547, NNF17OC0027232, NNF10OC1013354, NNF25SA0103783; Finnish Diabetes Research Foundation; Finnish Foundation for Cardiovascular Research; Paulo Foundation; Sigrid Jusélius Foundation; University of Helsinki and Helsinki University Hospital; Government Research Funds. Funding sources were not involved in the interpretation of data, writing of the manuscript, and the decision to submit the article.


Last updated on 04/12/2025 01:52:41 PM